Rotech bolsters its clinical oversight

Wednesday, August 31, 2005

ORLANDO, Fla. -- Rotech Healthcare has reshuffled the company's clinical oversight. Last month, the company promoted Greg Spratt to chief clinical officer last month. Spratt will be responsible for oversight of all aspects of Rotech's clinical programs, including the operation of PulmoDose Pharmacy and Sleep Central. Spratt has been with Rotech for 18 years and most recently served as the company's national clinical director. The company has hired Nick Macmillan to fill that position. Macmillan has more than 25 years of respiratory healthcare experience. He'll be responsible for the ongoing development and expansion of Rotech's clinical programs. For the past four years, he worked for Sunrise Medical - DeVilbiss, where he most recently served as global sleep product director.